Karin Amundson, BSc

Senior Research Associate
Cidara Therapeutics
San Diego, California, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 2062 - In Vivo Efficacy of CD388, a Novel Drug Fc-Conjugate (DFC), Against Seasonal Subtypes of Influenza in Prophylaxis in Immune Competent Mice, and in a Severe Immunodeficient (SCID) Mouse Model

  Saturday, October 14, 2023
  10:30 AM – 10:42 AM US ET